Chances are, your family physician hasn’t received $500,000
for speaking fees by big pharmaceutical.
According to an excellent article
by Salon, however, many influential
doctors do see their bottom lines enriched by companies that have an interest
in miracle drugs and devices being either prescribed or required for use.
Doctors who sit on quasi-government boards that push for
things like requiring commercial drivers be tested for sleep apnea, for
instance, are a valuable target, Salon
says.
As it turns out, comprehensive reform of America’s medical
system will bring a new layer of transparency into the murky world of drug and
device makers and payments to physicians.
Derided as “Obamacare” by some, the Affordable Care Act will
do something all Americans should applaud. It will expose financial ties
between Big Pharma (and Big Sleep) and the doctors who take an oath to “do no
harm.”
According to Salon,
beginning next year, pharmaceutical companies and medical device manufacturers
will be required to publicly report what they pay physicians who pimp their products.
Companies that pay six-figure speaking fees and other marketing to physicians
will report those expenditures to a federal database.
As Land Line has reported in the past, ties run
deep between Big Sleep and advisory boards like the FMCSA Medical Review
Boards, which has indicated a willingness to require expensive testing for
drivers.
While medical and insurance industries adjust to the ACA’s
new provisions, truck drivers will be able to see who is influencing these
decision makers. It’s good to see a law bring transparency to one of our
nation’s wealthiest and most powerful industries.

It is about time something was done about this problem. I have a big problem with being told I need the latest greatest drug. Just because some big busted drug rep was pushing it when her and the Doc were last together. There is a reason drug companies hire bimbos for reps.
ReplyDeleteInformative. Thanks Charlie.
ReplyDeleteThis law is a big step forward for consumer protection. Hopefully, it will protect the public from potentially harmful prescription drugs. How will patients get access to which doctors are on this list? Will a physician have to disclose that he or she is receiving funding from a pharmaceutical company when they prescribe a medication?
ReplyDelete